Bristol-Myers Squibb Company
Research Bristol-Myers Squibb Company (BMY) on Bullrun: valuation model: 22.1% undervalued, market cap USD 119.58B, P/E 16.4, dividend yield 4.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBMY
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-General
- CurrencyUSD
- Valuation signal22.1% undervalued
- Market capUSD 119.58B
- P/E16.4
- Dividend yield4.3%
- Financial periodFY2025
- RevenueUSD 48.19B
- Revenue growth-0.2%
- Net incomeUSD 7.05B
- Free cash flowUSD 12.85B
- Gross margin71.1%
Valuation Snapshot
Bullrun's latest valuation model marks Bristol-Myers Squibb Company as 22.1% undervalued; latest market cap is USD 119.58B; P/E is 16.4; dividend yield is 4.3%.
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma;
Frequently asked questions
Is Bristol-Myers Squibb Company overvalued or undervalued?
Bullrun's valuation model currently marks Bristol-Myers Squibb Company as 22.1% undervalued.
What is Bristol-Myers Squibb Company's market cap?
Bristol-Myers Squibb Company's market capitalization is USD 119.58B.
What is Bristol-Myers Squibb Company's P/E ratio?
Bristol-Myers Squibb Company's price-to-earnings (P/E) ratio is 16.4.
Does Bristol-Myers Squibb Company pay a dividend?
Bristol-Myers Squibb Company has a dividend yield of 4.3%.
What does Bristol-Myers Squibb Company do?
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications.